{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:08Z","timestamp":1761518888732},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5889,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1992,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p> <jats:sc>objective<\/jats:sc> Because of continued debate about the role of Insulin in the development of hirsutism and in the induction of the polycystic ovary syndrome, we have evaluated the hormonal pattern in a group of hirsute patients<\/jats:p><jats:p> <jats:sc>patients<\/jats:sc> Fifty\u2010four hirsute patients (age range 18\u201339 years) of whom 26 patients were obese (O) (BMI 28\u201353 kg\/m<jats:sup>2<\/jats:sup> and W\/H &lt; 0\u00b785), 12 with ultrasonographic evidence of polycystic ovaries (O PCO) and 14 with normal ovaries. Twenty\u2010eight patients were within normal weight range, and, of these, 14 presented ultrasonographic evidence of polycystic ovaries and 14 had normal ovaries. Two groups of age\u2010matched subjects (obese and normal weight), normally menstruating, without hirsutism or history of endocrinopathies or ultrasonographic evidence of polycystic ovaries, served as controls.<\/jats:p><jats:p> <jats:sc>measurements<\/jats:sc> Androstenedione and testosterone were evaluated in all patients by RIA, following ether extraction, DHEAS, LH, FSH and insulin were evaluated directly by RIA. SHBG was evaluated by the concanavalin method. Free testosterone (FT%) was calculated according to the formula FT = 4\u00b7038\u20131\u00b7607 log SHBG. integrated areas under the response curve were calculated for LH and insulin respectively following i.v. administration of GnRH (100 <jats:italic>\u03bc<\/jats:italic> g) or oral administration of glucose (75 g).<\/jats:p><jats:p> <jats:sc>results<\/jats:sc> Results (mean \u00b1 standard deviation) showed comparable values of androstenedione in all groups of obese patients and in obese controls (7\u00b73 \u00b1 2\u00b76 in patients with polycystic ovaries, 7\u00b71 \u00b1 2\u00b79 in non\u2010polycystic ovary patients and 7\u00b74 \u00b1 2\u00b76 nmol\/l in obese controls, respectively), regardless of baseline and area insulin, the presence or absence of polycystic ovaries, or hirsutlsm. SHBG levels showed a similar pattern (24 \u00b1 10, 23\u00b78 \u00b1 7\u00b79 and 36 \u00b1 19 nmol\/l) as did the percentage of free testosterone, regardless of the presence or absence of hirsutism. Regression analysis of the insulin and LH values (baseline and area) against the androgens and SHBG plasma levels showed that only LH area correlated positively with testosterone (<jats:italic>r<\/jats:italic>= 0\u00b736, <jats:italic>P<\/jats:italic> &gt; 0\u00b703), androstenedione (<jats:italic>r<\/jats:italic>= 0\u00b744, <jats:italic>P<\/jats:italic> &gt; 0\u00b702), % free testosterone (<jats:italic>r<\/jats:italic>= 0\u00b753, <jats:italic>P<\/jats:italic> &gt; 0\u00b7001), testosterone\/SHBG ratio (<jats:italic>r<\/jats:italic>= 0\u00b739, <jats:italic>P<\/jats:italic> &gt; 0\u00b703) and inversely with SHBG (<jats:italic>r<\/jats:italic>=\u2013 0\u00b757, <jats:italic>P<\/jats:italic> &gt; 0\u00b7001).<\/jats:p><jats:p> <jats:sc>conclusions<\/jats:sc> These results showed (1) no linear relationship between high levels of insulin, ovarian androgen production or free hormone availability, and (2) make it very doubtful that insulin plays a primary role in polycystic ovarian syndrome or hirsutlsm<\/jats:p>","DOI":"10.1111\/j.1365-2265.1992.tb00958.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:40:37Z","timestamp":1205754037000},"page":"197-202","source":"Crossref","is-referenced-by-count":35,"title":["Lack of linear relationship between hyperinsulinaemia and hyperandrogenism"],"prefix":"10.1111","volume":"36","author":[{"given":"V.","family":"Toscano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mangiantlnl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sclarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-6-3-400"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-198409001-00019"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-5-904"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60060-2"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-5-386"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb03897.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1984.tb03225.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-1-131"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113864"},{"key":"e_1_2_1_11_1","unstructured":"Farah M.J. Givens J.R.&Kitabchi A.E. (1989)Inverse correlation of the fasting insulin c\u2010peptide and glucose levels with the production rate of dehydroepiandrosterone in the polycystic ovary syndrome with acanthosis nigricans. Program of the 71st Annual Meeting of the Endocrine Society 768 (abstract)."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1075"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb00457.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-5-1066"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-31-5-556"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198803033180906"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/1043-2760(90)90051-4"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90676-9"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-180"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-6-1027"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-5-1040"},{"key":"e_1_2_1_22_1","unstructured":"Pasupuleti V.&Horton R. (1990)Insulin\u2010like growth factor can alter steroid 5 alpha reductase activity and formation of dihydro\u2010testosterone in skin flbroblasts. Program of the 72nd Annual Meeting of the Endocrine Society 414(abstract)."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-460"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-8-2-132"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-122-2-581"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-12-1-3"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-95"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60070-5"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)59293-0"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0970379"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-2-288"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350293"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1992.tb00958.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1992.tb00958.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T09:27:18Z","timestamp":1698053238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1992.tb00958.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["10.1111\/j.1365-2265.1992.tb00958.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb00958.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}